{
  "docId": "019de074-f95f-763f-9a80-be3b653e0df1",
  "docSlug": "502ed4e7545b260f09647399e486ae2c",
  "documentTitle": "Matinas BioPharma | Investor Presentation Deck | 28 slides",
  "authorId": "matinas-biopharma",
  "authorName": "Matinas BioPharma",
  "documentKindSlug": "pitchdeck",
  "documentKindLabel": "Pitch deck",
  "sourceTypeSlug": "investor_relations",
  "sourceTypeLabel": "Investor relations",
  "presentationDate": "2023-05-01 00:00:00",
  "orientation": "landscape",
  "aspectRatio": 1.7777778,
  "pageNumber": 11,
  "pageCount": 28,
  "prevPage": 10,
  "nextPage": 12,
  "slideType": "solution",
  "function": "present_solution",
  "density": "balanced",
  "nDataPoints": 0,
  "notes": "Uses a 'Before-After-Bridge' style logic to frame the solution.",
  "elementsJson": null,
  "metadataConfidence": 1,
  "imagePath": null,
  "slideHref": "/slides/019de074-f95f-763f-9a80-be3b653e0df1/11",
  "deckHref": "/decks/019de074-f95f-763f-9a80-be3b653e0df1",
  "deckJsonHref": "/decks/019de074-f95f-763f-9a80-be3b653e0df1.json",
  "deckAnchorHref": "/decks/019de074-f95f-763f-9a80-be3b653e0df1#slide-11",
  "components": [
    {
      "bbox": {
        "h": 0.55,
        "w": 0.92,
        "x": 0.04,
        "y": 0.18
      },
      "kind": "framework",
      "text": "Innate Characteristics - Limitations + LNC Improvements = Solution",
      "attrs": null,
      "subkind": "instance",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "cb320484-a428-4625-ac1f-e7da0f58800a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.45,
        "w": 0.92,
        "x": 0.04,
        "y": 0.285
      },
      "kind": "table",
      "text": "Comparison of Innate Characteristics, Limitations, and LNC Improvements",
      "attrs": null,
      "subkind": "comparison",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "9f13e9e3-baf1-4360-b1b7-554118fc887d",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.08,
        "w": 0.64,
        "x": 0.18,
        "y": 0.82
      },
      "kind": "title",
      "text": "MAT2203 is a promising potential therapeutic option for the treatment of MULTIPLE serious and life-threatening fungal infections",
      "attrs": null,
      "subkind": "action-title",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "c25bfb4a-6c00-4593-9b86-bedb30c9427a",
      "frameworkName": null,
      "frameworkSlug": null
    },
    {
      "bbox": {
        "h": 0.05,
        "w": 0.77,
        "x": 0.03,
        "y": 0.05
      },
      "kind": "title",
      "text": "MAT2203: A Novel Approach to Developing the Ideal Antifungal Agent",
      "attrs": null,
      "subkind": "headline",
      "toolName": null,
      "toolSlug": null,
      "confidence": null,
      "componentId": "675d64ef-2c9d-4813-acb6-b785ef7e6907",
      "frameworkName": null,
      "frameworkSlug": null
    }
  ],
  "metrics": [],
  "tools": [],
  "frameworks": [
    {
      "name": "before-after-bridge",
      "slug": null,
      "matchId": "be00e82f-bbd0-4960-96b7-20284410bb97",
      "evidence": "The slide structure explicitly subtracts limitations from innate characteristics and adds improvements to arrive at the solution.",
      "confidence": 0.95
    }
  ],
  "arcBeats": [
    {
      "to": 12,
      "from": 11,
      "beatId": "5629e450-a723-4fb6-abf4-aceb2d66f265",
      "arcName": "The Sequoia Pitch",
      "arcSlug": "sequoia-pitch",
      "beatName": "Solution",
      "beatSlug": "sequoia-pitch-solution",
      "evidence": "The deck presents MAT2203 as a promising therapeutic option.",
      "position": 1,
      "confidence": 0.8,
      "parentBeatName": "Turn",
      "parentBeatSlug": "turn"
    }
  ],
  "loops": [
    {
      "to": 12,
      "from": 10,
      "name": "Cost Of Inaction",
      "slug": "27-cost-of-inaction",
      "bestFor": "Urgent budget requests, compliance, risk mitigation",
      "matchId": "c50fa4d6-4f37-4861-9ddc-c482a0ce90ef",
      "evidence": "The deck highlights the limitations of current treatment options and the potential benefits of MAT2203.",
      "position": 0,
      "objective": "What is the cost of not addressing the current limitations in treatment options?",
      "structure": "The Status Quo -> The Hidden Costs Accumulating -> The Future State of Inaction -> The Tipping Point",
      "confidence": 0.7,
      "description": "Quantify what happens if the audience does nothing"
    },
    {
      "to": 12,
      "from": 10,
      "name": "Why Now",
      "slug": "15-why-now",
      "bestFor": "Sales pitches, fundraising, requesting immediate budget approval",
      "matchId": "0540937d-e3f0-46a5-9468-eab2036e9b16",
      "evidence": "The deck presents the current state of the company and its future plans.",
      "position": 1,
      "objective": "Why is now the right time to invest in Matinas BioPharma?",
      "structure": "The Context (Trends) -> The Trigger Event -> The Window of Opportunity",
      "confidence": 0.6,
      "description": "Create temporal urgency by proving that the window of opportunity is opening or closing"
    }
  ],
  "imagePathAlt": null,
  "thumbSrc": null,
  "thumbSrcAlt": null,
  "locked": true
}